Lauersen N H, Wilson K H
Am J Obstet Gynecol. 1976 Jan 15;124(2):169-76. doi: 10.1016/s0002-9378(16)33294-x.
Midtrimester abortion was successfully induced in 117 of 120 patients with serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). The mean abortion time was 14.12 hours, and parous patients aborted in a mean of 12.85 hours-significantly faster than nulliparous patients who aborted in a mean of 15.24 hours. Ninety-four per cent of the 117 successfully induced abortions occurred in less than 24 hours and 46 per cent in less than 12 hours. Uterine activity was monitored and analyzed in nine patients. Uterine response to a single intramuscular injection of 100 mug of 15-me-PGF2alpha was characterized by the appearance of low-amplitude, high frequency contractions and a rapid increase in baseline intrauterine tonus. A high level of uterine activity, 900 Montevideo Units, was observed within 30 minutes of the first intramuscular injection of 15-me-PGF2alpha. This activity was not maintained and decreased by approximately 30 per cent at the time of the second injection at 1 hour. It was not until 6 hours of 15-me-PGF2alpha therapy that activity stabilized at approximately 500 Montevideo Units. Even though all patients were premedicated with antiemetic and antidiarrhea agents, 68 of 120 patients experienced gastrointestinal side effects related to the 15-me-PGF2alpha administration. Vomiting was the most prevalent side effect, occuring in 65 patients, but the episodes were not severe, were well tolerated by the patients and did not necessitate the termination of prostaglandin administration in any of the patients. In this study abortion was successfully induced between weeks 9 to 27 of gestation. It was observed that patients with gestations of 16 weeks or less aborted significantly faster than patients with gestations of 17 weeks or more, which indicates that this method is highly effective in the induction of abortion within the "gray zone", 12 to 16 weeks of gestation.
通过连续肌肉注射15(S)-15-甲基前列腺素F2α(15-甲基-PGF2α),120例患者中有117例成功诱导了中期流产。平均流产时间为14.12小时,经产妇平均流产时间为12.85小时,明显快于初产妇,初产妇平均流产时间为15.24小时。117例成功诱导流产的患者中,94%在24小时内流产,46%在12小时内流产。对9例患者的子宫活动进行了监测和分析。单次肌肉注射100μg 15-甲基-PGF2α后,子宫反应表现为低振幅、高频收缩以及基线子宫内压迅速升高。在首次肌肉注射15-甲基-PGF2α后30分钟内,观察到子宫活动水平达到900蒙得维的亚单位。这种活动未持续,在1小时后第二次注射时下降了约30%。直到15-甲基-PGF2α治疗6小时后,活动才稳定在约500蒙得维的亚单位。尽管所有患者都预先使用了止吐和止泻药物,但120例患者中有68例出现了与15-甲基-PGF2α给药相关的胃肠道副作用。呕吐是最常见的副作用,65例患者出现呕吐,但发作并不严重,患者耐受性良好,且没有任何患者因此需要终止前列腺素给药。在本研究中,妊娠9至27周之间成功诱导了流产。观察到妊娠16周或更短的患者流产明显快于妊娠17周或更长的患者,这表明该方法在妊娠“灰色地带”(12至16周)内诱导流产非常有效。